William Blair Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-528,404
Closed -$17M 426
2019
Q1
$17M Buy
528,404
+138,780
+36% +$4.29M 0.07% 245
2018
Q4
$11M Buy
389,624
+120,010
+45% +$3.51M 0.05% 292
2018
Q3
$7.75M Buy
269,614
+40,151
+17% +$1.21M 0.03% 344
2018
Q2
$8.59M Buy
229,463
+130,392
+132% +$5.12M 0.03% 341
2018
Q1
$3.89M Buy
+99,071
New +$3.62M 0.01% 364

Other funds holding XENT

William Blair Investment Management's XENT Position: Q2 2019 in Review

William Blair Investment Management sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 528,404 shares — an estimated $17M sold.

William Blair Investment Management first reported a position in XENT in Q1 2018 and held it in 5 quarters. The position peaked at $17M in Q1 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

  • William Blair Investment Management reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
  • William Blair Investment Management sold 528,404 Intersect ENT, Inc shares in Q2 2019, an estimated $17M.
  • William Blair Investment Management first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 5 quarters.
  • William Blair Investment Management's Intersect ENT, Inc position peaked at $17M in Q1 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on William Blair Investment Management's 13F filing for Q2 2019, filed 9 Aug 2019.